Gene therapy of human somatotroph and lactotroph pituitary adenomas using an adenoviral virus expressing the somatostatin receptor type 2

被引：0
|
作者：
Acunzo, Julie [1 ]
Roche, Catherine [1 ]
Thirion, Sylvie [1 ]
Saveanu, Alexandru [1 ]
Gunz, Ginette [1 ]
Germanetti, Anne Laure [2 ]
Couderc, Bettina [3 ]
Brue, Thierry [4 ]
Enjalbert, Alain [1 ]
Barlier, Anne [1 ]
机构：
[1] Univ Aix Marseille 2, CNRS, UMR 6231, Marseille, France
[2] Ctr Hosp Univ Concept, Lab Biochim & Biol Mol, Marseille, France
[3] Univ Toulouse, Inst Claudius Regaud, Toulouse, France
[4] Ctr Hosp Univ Timone, Dept Endocrinol, Marseille, France
来源：
HUMAN GENE THERAPY | 2008年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1107 / 1107
页数：1
相关论文
共 50 条
  • [1] Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas
    Petersenn, S
    Heyens, M
    Lüdecke, DK
    Beil, FU
    Schulte, HM
    CLINICAL ENDOCRINOLOGY, 2000, 52 (01) : 35 - 42
  • [2] Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression
    PellegriniBouiller, I
    MorangeRamos, I
    Barlier, A
    Gunz, G
    FigarellaBranger, D
    CortetRudelli, C
    Grisoli, F
    Jaquet, P
    Enjalbert, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09): : 3390 - 3396
  • [3] Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas
    Stefaneanu, L
    Kovacs, K
    Thapar, K
    Horvath, E
    Melmed, S
    Greenman, Y
    ENDOCRINE PATHOLOGY, 2000, 11 (01) : 41 - 48
  • [4] Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas
    Lucia Stefaneanu
    Kalman Kovacs
    Kamal Thapar
    Eva Horvath
    Shlomo Melmed
    Yona Greenman
    Endocrine Pathology, 2000, 11 : 41 - 48
  • [5] Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro
    Zatelli, C
    Piccin, D
    Tagliati, F
    Bottoni, A
    Ambrosio, MR
    Margutti, A
    Scanarini, M
    Bondanelli, M
    Culler, MD
    Uberti, EC
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2005, 35 (02) : 333 - 341
  • [6] Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2
    Ferrante, E.
    Pellegrini, C.
    Bondioni, S.
    Peverelli, E.
    Locatelli, M.
    Gelmini, P.
    Luciani, P.
    Peri, A.
    Mantovani, G.
    Bosari, S.
    Beck-Peccoz, P.
    Spada, A.
    Lania, A.
    ENDOCRINE-RELATED CANCER, 2006, 13 (03) : 955 - 962
  • [7] Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas:: analysis of gene sequence and mRNA expression
    Corbetta, S
    Ballaré, E
    Mantovani, G
    Lania, A
    Losa, M
    Di Blasio, AM
    Spada, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (03) : 208 - 214
  • [8] IN-SITU HYBRIDIZATION STUDY OF OCTREOTIDE EFFECT ON GROWTH-HORMONE (GH) AND SOMATOSTATIN SUBTYPE-2 RECEPTOR (SSTR2) MESSENGER-RNAS IN HUMAN PITUITARY SOMATOTROPH ADENOMAS
    STEFANEANU, L
    THAPAR, K
    HORVATH, E
    KOVACS, K
    EZZAT, S
    LANCRANJAN, I
    FASEB JOURNAL, 1995, 9 (03): : A268 - A268
  • [9] The type 2 human somatostatin receptor as a platform for reporter gene imaging
    Kurt R. Zinn
    Tandra R. Chaudhuri
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 388 - 399
  • [10] The type 2 human somatostatin receptor as a platform for reporter gene imaging
    Zinn, KR
    Chaudhuri, TR
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (03) : 388 - 399
12345